These complications are monitored with laboratory tests (hemoglobin [Hgb] and iron saturation [Tsat] for anemia; parathyroid hormone [PTH], calcium, and phosphate for MBD).1,2 The optimal frequency of this surveillance blood work in dialysis patients (CKD5D) is unknown. This evidence concerns the gene PTH and Marchiafava-Bignami disease.